抗凝血酶Ⅲ通过降低肺泡屏障通透性减轻脓毒症急性肺损伤

李东旭; 宋振举; 王璐; 于兵; 戴青青

doi:10.14188/j.1671-8852.2024.0496

您当前的位置：

首页 >

文章列表页 >

抗凝血酶Ⅲ通过降低肺泡屏障通透性减轻脓毒症急性肺损伤

急性呼吸窘迫综合征专题研究 | 更新时间：2026-11-05

- 抗凝血酶Ⅲ通过降低肺泡屏障通透性减轻脓毒症急性肺损伤
- Antithrombin Ⅲ reduces sepsis⁃induced acute lung injury by reducing alveolar barrier permeability
- 武汉大学学报（医学版） 2025年46卷第2期页码：153-159
- 作者机构：
  
  1.复旦大学附属妇产科医院重症医学科上海 200082
  2.复旦大学附属中山医院急诊科/复旦大学应急救援与急危重症研究所上海 200032
  3.武汉大学人民医院重症医学科湖北武汉 430060
  4.中国人民解放军海军军医大学细胞生物学教研室上海 200433
- 作者简介：
  
  李东旭，女，1993—，主要从事脓毒症的临床和基础研究，E⁃mail:1362371074@qq.com
  戴青青，女，1986—，医学博士，副主任医师，主要从事脓毒症/ARDS的临床和基础研究，E⁃mail: daiqingqing888@126.com
- 基金信息：
  
  国家重点研发计划项目(2021YFC2501800);国家自然科学基金青年科学基金(82002077);上海市公共卫生体系建设三年行动计划(GWVI⁃2.1⁃3)
- DOI：10.14188/j.1671-8852.2024.0496
  中图分类号： R56
- 收稿：2024-09-10，
  
  纸质出版：2025-02-25
- 稿件说明：
移动端阅览
李东旭,宋振举,王璐等.抗凝血酶Ⅲ通过降低肺泡屏障通透性减轻脓毒症急性肺损伤[J].武汉大学学报（医学版）,2025,46(02):153-159.

LI Dongxu,SONG Zhenju,WANG Lu,et al.Antithrombin Ⅲ reduces sepsis⁃induced acute lung injury by reducing alveolar barrier permeability[J].Medical Journal of Wuhan University,2025,46(02):153-159.
李东旭,宋振举,王璐等.抗凝血酶Ⅲ通过降低肺泡屏障通透性减轻脓毒症急性肺损伤[J].武汉大学学报（医学版）,2025,46(02):153-159. DOI： 10.14188/j.1671-8852.2024.0496.

LI Dongxu,SONG Zhenju,WANG Lu,et al.Antithrombin Ⅲ reduces sepsis⁃induced acute lung injury by reducing alveolar barrier permeability[J].Medical Journal of Wuhan University,2025,46(02):153-159. DOI： 10.14188/j.1671-8852.2024.0496.

摘要

目的

探讨抗凝血酶Ⅲ(ATⅢ)对脓毒症急性肺损伤肺泡屏障的保护作用。

方法

将雄性C57BL/6J小鼠随机分成3组，①脓毒症组（LPS组）：将小鼠饥饿16 h后，腹腔注射20 mg/kg 脂多糖（LPS）；②脓毒症+ATⅢ组（LPS+ATⅢ组）：LPS注射2 h后，尾静脉注射750 IU/kg ATⅢ；③对照组（Control组）：参照LPS和ATⅢ的给药途径与时间分别注射等体积生理盐水。在ATⅢ给药24 h后收集血清、肺泡灌洗液以及肺组织等标本，采用HE染色结合肺损伤评分评价肺组织的形态结构与损伤程度；采用肺湿/干重比（W/D）、肺泡灌洗液（BALF）中的细胞数量与蛋白量以及FITC⁃Dextran渗透实验测量肺泡屏障通透性；采用免疫组织学染色检测肺组织细胞间紧密连接组成蛋白的表达量。

结果

LPS组的肺损伤评分、肺湿/干重比（W/D值）、肺泡屏障通透性均较Control组显著升高（

0.01），细胞间紧密连接的组成蛋白ZO⁃1、Occludin和Claudin3的表达水平均显著降低（

0.001）。而LPS+ATⅢ组的肺损伤评分、W/D值、肺泡屏障通透性较LPS组均降低（

0.05），ZO⁃1、Occludin和Claudin3表达水平升高（

0.01）。

结论

ATⅢ增加细胞间紧密连接组成蛋白的表达

进而降低肺泡屏障的通透性，从而减轻脓毒症急性肺损伤。

Abstract

Objective

To explore the protective effect of antithrombin Ⅲ (ATⅢ) on the alveolar barrier in acute lung injury induced by sepsis.

Methods

Male C57BL/6J mice were randomly divided into three groups

①sepsis group (LPS group): after fasting the mice for 16 hours

20 mg/kg lipopolysaccharide (LPS) was injected intraperitoneally; ②sepsis treated with ATⅢ group (LPS+ATⅢ group): 750 IU/kg ATⅢ was injected via the tail vein 2 hours after LPS injection; ③control group: equal volume of saline were injected according to the strategies of the administration of LPS and ATⅢ. The serum

bronchoalveolar lavage fluid (BALF)

and lung tissue samples were collected 24 hours after ATⅢ administration. HE staining combined with lung injury scoring was used to assess the morphological structure and degree of damage in lung tissues; the lung wet/dry weight ratio (W/D)

cell count and protein content in BALF

and FITC⁃Dextran permeability assay were employed to measure pulmonary barrier permeability; immunohistochemical staining was utilized to detect the expression levels of tight junction proteins in lung tissues.

Results

The lung injury score

lung W/D value and the permeability of the alveolar barrier in the LPS group were significantly increased as compared with those in the control group (

0.01); the expression levels of the components of tight junctions

ZO⁃1

occludin

and Claudin3 were significantly reduced (

0.001). However

the lung injury score

W/D value

and the permeability of the alveolar barrier in the LPS+ATⅢ group were lower than those in the LPS group (

0.05)

and the expression level of ZO⁃1

occludin

and Claudin3 was higher (

0.01).

Conclusion

ATⅢ reduces the permeability of the alveolar barrier by increasing the expression of tight junction proteins

thus alleviating acute lung injury induced by sepsis.

关键词

Keywords

references

Darkwah S , Kotey F C N , Ahenkorah J , et al . Sepsis⁃related lung injury and the complication of extrapulmonary pneumococcal pneumonia [J ] . Diseases , 2024 , 12 ( 4 ): 72 .

Wick K D , Aggarwal N R , Curley M A Q , et al . Opportunities for improved clinical trial designs in acute respiratory distress syndrome [J ] . Lancet Respir Med , 2022 , 10 ( 9 ): 916 ⁃ 924 .

Gorman E A , O'Kane C M , McAuley D F . Acute respiratory distress syndrome in adults: Diagnosis, outcomes, long⁃term sequelae, and management [J ] . Lancet , 2022 , 400 ( 10358 ): 1157 ⁃ 1170 .

Murakami K , McGuire R , Cox R A , et al . Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep [J ] . Crit Care Med , 2003 , 31 ( 2 ): 577 ⁃ 583 .

Iba T , Levy J H , Hirota T , et al . Protection of the endothelial glycocalyx by antithrombin in an endotoxin⁃induced rat model of sepsis [J ] . Thromb Res , 2018 , 171 : 1 ⁃ 6 .

Okamoto H , Muraki I , Okada H , et al . Recombinant antithrombin attenuates acute respiratory distress syndrome in experimental endotoxemia [J ] . Am J Pathol , 2021 , 191 ( 9 ): 1526 ⁃ 1536 .

Wiedermann C J . Antithrombin as therapeutic intervention against sepsis⁃induced coagulopathy and disseminated intravascular coagulation: Lessons learned from COVID⁃19⁃associated coagulopathy [J ] . Int J Mol Sci , 2022 , 23 ( 20 ): 12474 .

Biswas I , Panicker S R , Cai X S , et al . Extracellular histones bind vascular glycosaminoglycans and inhibit the anti⁃inflammatory function of antithrombin [J ] . Cell Physiol Biochem , 2021 , 55 ( 5 ): 605 ⁃ 617 .

Zhu L J , Zhang Y , Zhang Z F , et al . Activation of PI3K/Akt/HIF⁃1α signaling is involved in lung protection of dexmedetomidine in patients undergoing video⁃assisted thoracoscopic surgery: A pilot study [J ] . Drug Des Devel Ther , 2020 , 14 : 5155 ⁃ 5166 .

Qian T T , Qi B Y , Fei Y X , et al . PLD2 deletion alleviates disruption of tight junctions in sepsis⁃induced ALI by regulating PA/STAT3 phosphorylation pathway [J ] . Int Immunopharmacol , 2023 , 114 : 109561 .

郝梦瑶 . 鞘氨醇⁃1⁃磷酸⁃1型受体激动剂IMMH002保护肺泡屏障稳态改善肺纤维化的机制研究 [D ] . 北京 : 中国医学科学院 , 2023 .

Hao M Y . The study on the mechanism of IMMH002, an agonist of sphingosine⁃1⁃phosphate type 1 receptor, in protecting alveolar barrier homeostasis and ameliorating pulmonary fibrosis [D ] . Beijing : Chinese Academy of Medical Sciences , 2023 .

Brune K , Frank J , Schwingshackl A , et al . Pulmonary epithelial barrier function: Some new players and mechanisms [J ] . Am J Physiol Lung Cell Mol Physiol , 2015 , 308 ( 8 ): L731 ⁃L745.

Umeda K , Ikenouchi J , Katahira⁃Tayama S , et al . ZO⁃1 and ZO⁃2 independently determine where claudins are polymerized in tight⁃junction strand formation [J ] . Cell , 2006 , 126 ( 4 ): 741 ⁃ 754 .

Rahimi N . Defenders and challengers of endothelial barrier function [J ] . Front Immunol , 2017 , 8 : 1847 .

Kuo W T , Odenwald M A , Turner J R , et al . Tight junction proteins occludin and ZO⁃1 as regulators of epithelial proliferation and survival [J ] . Ann N Y Acad Sci , 2022 , 1514 ( 1 ): 21 ⁃ 33 .

Takahashi Y , Kawasaki T , Sato H , et al . Functional roles for CD26/DPP4 in mediating inflammatory responses of pulmonary vascular endothelial cells [J ] . Cells , 2021 , 10 ( 12 ): 3508 .

Yang J , Wang Y , Liu H , et al . C2⁃ceramide influences alveolar epithelial barrier function by downregulating ZO⁃1, occludin and claudin⁃4 expression [J ] . Toxicol Mech Methods , 2017 , 27 ( 4 ): 293 ⁃ 297 .

Di Lorenzo F , Duda K A , Lanzetta R , et al . A journey from structure to function of bacterial lipopolysaccharides [J ] . Chem Rev , 2022 , 122 ( 20 ): 15767 ⁃ 15821 .

Rezaie A R , Giri H . Anticoagulant and signaling functions of antithrombin [J ] . J Thromb Haemost , 2020 , 18 ( 12 ): 3142 ⁃ 3153 .

Rodgers G M , Mahajerin A . Antithrombin therapy: Current state and future outlook [J ] . Clin Appl Thromb Hemost , 2023 , 29 : 10760296231205279 .

浏览量

234

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

双硫仑抑制细胞焦亡改善脓毒症小鼠急性肺损伤的作用机制

血红蛋白β亚基通过调控肺血管内皮糖酵解减轻脓毒症急性肺损伤

抑制UBE2O通过上调BMAL1减轻脓毒症急性肺损伤

血液净化联合乌司他丁治疗对脓毒症合并急性肺损伤患者外周血HMGB1、IL⁃6、IL⁃17和IL⁃33的影响

ICU严重多发伤并发急性呼吸窘迫综合征的危险因素分析